site stats

Cntx earnings

WebMar 24, 2024 · Context Therapeutics Inc CNTX:NASDAQ EXPORT WATCHLIST + RT Quote Last NASDAQ LS, VOL From CTA USD After Hours: Last 03/24/23 EDT 0.62 … WebMar 29, 2024 · Context Therapeutics Inc. (NASDAQ:CNTX – Get Rating) – HC Wainwright issued their Q1 2024 earnings per share (EPS) estimates for Context Therapeutics in a research report issued on Thursday, March 23rd.HC Wainwright analyst E. Bodnar expects that the company will post earnings per share of ($0.16) for the quarter. HC Wainwright …

Context Therapeutics Inc. (CNTX) - Yahoo Finance

Web2 hours ago · CNTX + Free Alerts is a biopharmaceutical company committed to advancing medicines for solid tumors by harnessing novel and innovative treatment targets such as … WebA number of insiders bought Context Therapeutics Inc. (NASDAQ:CNTX) stock last year, which is great news for shareholders. Generally, when a single insider buys stock, it is usually not a big deal ... crvena bela plava zastava https://caneja.org

Context Therapeutics Inc. (CNTX) - Stock Analysis

WebCNTX : 0.6051 (+3.42%) Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination Newswire.ca - Tue Aug 2, 2024. /CNW/ -- Context Therapeutics Inc. ("Context" or the "Company") (Nasdaq: CNTX), a women's oncology company developing small … WebMar 22, 2024 · PHILADELPHIA, PA— March 22, 2024—Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company developing novel treatments for solid tumors, today announced financial results for the year ended December 31, 2024.Additionally, the Company announced a portfolio prioritization and … WebOn Invalid Date, Context Therapeutics (NASDAQ: CNTX) reported Q4 2024 earnings per share (EPS) of -$0.22, up 101.29% year over year. Total Context Therapeutics earnings … اغاني سيف نبيل حزينه جدا

CNTX Earnings Dates, Upcoming and Historical Context …

Category:Significant Unmet Need In Solid Tumors Reported, And …

Tags:Cntx earnings

Cntx earnings

Context Therapeutics Inc. (CNTX) - Stock Analysis

WebMar 27, 2024 · Context Therapeutics Inc. (NASDAQ:CNTX – Get Rating) – HC Wainwright issued their Q1 2024 earnings per share (EPS) estimates for Context Therapeutics in a note issued to investors on Thursday ... WebJul 1, 2024 · new earnings signals; insider trading; insider tracker; estimize forecasts; risk factors ... amr opof rna bzfd weth lscc lwlg arnc dvax atlo ke dg adom trup geo lask amrs aspu cyrx pkg alv nie cvs stel abeo strs jewl awh seel smap lind mtex pnr cntx mtz silk rvmd aht inod trmb vcnx forg gbny lrfc blco clsk tyme tech snx drna zts ambc reemf dtgi ...

Cntx earnings

Did you know?

WebApr 3, 2024 · Gentex Corporation (GNTX) latest earnings report: revenue, EPS, surprise, history, news and analysis. WebMar 27, 2024 · Context Therapeutics Inc. (NASDAQ:CNTX – Get Rating) – HC Wainwright issued their Q1 2024 earnings per share estimates for Context Therapeutics in a research report issued on Thursday, March 23rd.

WebA number of insiders bought Context Therapeutics Inc. (NASDAQ:CNTX) stock last year, which is great news for shareholders. Generally, when a single insider buys stock, it is … Web2 hours ago · Context Therapeutics Inc. CNTX is a biopharmaceutical company committed to advancing medicines for solid tumors by harnessing novel and innovative treatment targets such as Claudin 6 (CLDN6). A ...

WebContext Therapeutics Inc. analyst estimates, including CNTX earnings per share estimates and analyst recommendations. WebFeb 14, 2024 · Find the latest SEC Filings data for Context Therapeutics Inc. Common Stock (CNTX) at Nasdaq.com. Context Therapeutics Inc. Common Stock (CNTX) SEC …

WebMar 23, 2024 · The following information was filed by Context Therapeutics Inc. (CNTX) on Wednesday, March 23, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the …

WebApr 10, 2024 · Get a real-time Context Therapeutics Inc. (CNTX) stock price quote with breaking news, financials, statistics, charts and more. ... Earnings Date: May 10, 2024: About CNTX. Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead … crvena apoteka banja luka radno vrijemeWebThe value each CNTX share was expected to gain vs. the value that each CNTX share actually gained. (CNTX) reported earnings per share (EPS) of $0, — estimates of $0 by … crvena boja znacenjeWebContext Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CNTX updated stock price target summary. Dow Jones, a News Corp company … اغاني سيف نبيل حزينهWebCNTX Earnings Date Earnings Per Share Estimated Reported 3Q'21 4Q'21 1Q'22 2Q'22 3Q'22 4Q'22 1Q'23 2Q'23 -5-4-3-2-10 EPS Quarterly Earnings Surprise Amount Yearly … اغاني سيف نبيل 2021 mp3WebEarnings Summary For their last quarter, Context Therapeutics Inc. (CNTX) reported earnings of -$0.24 per share, beating the Zacks Consensus Estimate of $-0.25 per … crvena boja značenjeWebMar 17, 2024 · Context Therapeutics Inc. (CNTX) latest earnings report: revenue, EPS, surprise, history, news and analysis. Context Therapeutics Inc. (CNTX) Earnings … crvena boja koseWebContext Therapeutics (CNTX) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... The company reported -$0.24 earnings per share for the quarter, beating the consensus estimate of -$0.25 by $0.01. Is Context Therapeutics overvalued? According to Wall ... crvena bolna kvržica ispod pazuha